Skip to main content


Cognitive enhancers for ageing and Alzheimer's disease

Edited by Howard Fillit

This series of articles, published in Alzheimer's Research & Therapy, has not been sponsored. All articles have undergone the journal’s standard peer review process overseen by the Series Editor, with final decisions made by the Editors in Chief. The Series Editor and Editors in Chief declare no competing interests.

  1. Editorial

    Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease

    Increased knowledge of the biology of synaptic function has led to the development of novel cognitive-enhancing therapeutic strategies with the potential for increased efficacy and safety. This editorial highl...

    Diana W Shineman, Aaron J Carman, Penny A Dacks, Rachel F Lane and Howard M Fillit

    Alzheimer's Research & Therapy 2013 5:45

    Published on: 2 October 2013

  2. Review

    Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

    The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new therapies to delay or prevent symptom onset and progression. There is growing awareness that clinical trials must target s...

    Termpanit Chalermpalanupap, Becky Kinkead, William T Hu, Markus P Kummer, Thea Hammerschmidt, Michael T Heneka, David Weinshenker and Allan I Levey

    Alzheimer's Research & Therapy 2013 5:21

    Published on: 29 April 2013

  3. Review

    5-HT6 receptors and Alzheimer's disease

    During the past 20 years, the 5-HT6 receptor has received increasing attention and become a promising target for improving cognition. Several studies with structurally different compounds have shown that not only...

    María Javier Ramírez

    Alzheimer's Research & Therapy 2013 5:15

    Published on: 22 April 2013